Xpect-At Oral Tablet, Extended Release 60-600Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Xpect-AT: Oral tablet, extended release (60-600mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_8585.JPG
GFN/Carbetap 600mg-60mg ER Tab
Brighton Pharmaceuticals
Pill Identification: BP 960 
Drug Image file DrugItem_7295.JPG
Xpect-AT 60mg-600mg ER Tab
Hawthorn Pharmaceuticals
Pill Identification: HAW240 

What is this Medicine?

CARBETAPENTANE; GUAIFENESIN (kar bay ta PEN tane; gwye FEN e sin) is a combination of a cough suppressant and expectorant. It is used to provide relief from cough. This medicine will not treat an infection.

In-Depth Information

Xpect-AT 60mg-600mg Extended-Release Tablet

NDC: 637170240
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Cough, Sinusitis, Common Cold

Sometimes used for but not FDA approved for the following conditions:
Bronchitis

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Xpect-AT 60mg-600mg Extended-Release Tablet
Drug Image file DrugItem_7295.JPG
Hawthorn Pharmaceuticals
Pill Identification: HAW240 
Shape: oblong
Color: white
Daily Life Interactions for Xpect-AT 60mg-600mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Xpect-AT 60mg-600mg Extended-Release Tablet(Carbetapentane Citrate)
Alcohol and Carbetapentane(Carbetapentane Citrate)
You may feel drowsy or more tired if you have alcohol-containing drinks while taking products that contain Carbetapentane. Decreased alertness, drowsiness, falls, or other side effects may occur. Do not drive or operate machinery if you are drinking alcohol-containing beverages.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Xpect-AT

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5